National Stroke Foundation

Gonal-F (follitropin alfa for injection)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved September 1997

Specific Treatments:


General Information

Gonal-F (follitropin alfa for injection) has received marketing clearance from the U.S. Food and Drug Administration (FDA). Gonal-F is indicated for ovulation induction and for use in conjunction with assisted reproductive technologies, such as in vitro fertilization.